Clinical Trials Logo

Filter by:
NCT ID: NCT05861076 Active, not recruiting - Side Effect Clinical Trials

Moringa Powder Acceptability Trial Among Healthy Adults

Start date: January 3, 2023
Phase: N/A
Study type: Interventional

The study is a randomized acceptability trial involving the provision of three different doses of Moringa powder to be consumed daily by study participants.

NCT ID: NCT05860413 Active, not recruiting - Type 2 Diabetes Clinical Trials

Intermittent Fasting for the Treatment of Type 2 Diabetes Mellitus

Start date: January 24, 2023
Phase: N/A
Study type: Interventional

To test whether a lifestyle program featuring one of two forms of intermittent fasting (IER or TRE) can feasibly and effectively improve glycemia in patients with type 2 diabetes, and potentially induce diabetes remission.

NCT ID: NCT05860127 Active, not recruiting - Dementia Clinical Trials

Cognitive Stimulation Therapy for Dementia: A Two-Armed Pragmatic Trial

Start date: April 10, 2023
Phase: N/A
Study type: Interventional

Cognitive Stimulation Therapy (CST) is an evidence-based non-pharmacological group therapy shown to benefit people with mild to moderate dementia. Despite increasing availability of CST worldwide, access remains limited in the United States. This pilot pragmatic trial will embed CST referral into the standard care protocol of health care settings that serve people living with dementia in the state of Connecticut, and evaluate online delivery of CST known as virtual CST (V-CST), and assess the acceptability of V-CST to people living with dementia. The study design is a two-armed randomized embedded pragmatic clinical trial (ePCT). The trial aims to determine if cognitive decline is experienced less commonly among V-CST participants than control group members based on three widely used measures of cognition, the Montreal Cognitive Assessment (MoCA), St. Louis University Memory Screen (SLUMS), and Mini Mental State Exam (MMSE). The study population will be persons with mild to moderate dementia identified by clinicians in standard care. From this population, subject participants will be randomized to intervention and control groups. Patients randomly assigned to the intervention group will be referred by their clinical providers to participate in V-CST, and those who accept the referral will participate in the intervention.

NCT ID: NCT05859776 Active, not recruiting - Clinical trials for Neovascular Age-related Macular Degeneration

Safety and Bioactivity of AXT107 in Subjects With Neovascular Age-Related Macular Degeneration (nAMD)

DISCOVER
Start date: December 19, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

The goal of this clinical trial is to understand the safety of AXT107 injected suprachoroidally in participants with nAMD. The main question[s] it aims to answer are: - Safety of the maximum tolerable dose of AXT107 - Bioactivity and duration of action of AXT107 injected suprachoroidally Participants will be injected with AXT107 and will be followed on a regular monitoring visits through 9 months post single injection.

NCT ID: NCT05859386 Active, not recruiting - Depression Clinical Trials

Optimizing Mindfulness Based Cognitive Therapy (MBCT) Maintenance

OMM
Start date: April 3, 2023
Phase: N/A
Study type: Interventional

Mindfulness-Based Cognitive Therapy (MBCT) combines meditation practices from Mindfulness-Based Stress Reduction (MBSR) with cognitive behavioral therapy to improve mental health. Although there is evidence that MBCT provides a variety of mental health benefits, it is particularly designed to prevent depression relapse, which occurs in 80% of people with a history of two episodes of depression. MBCT reduces depression relapse rates by 30%, on average after an eight-week course, and has lower relapse rates than continuing antidepressant medication. However, it is unknown what should be done following the program to optimize its long-term benefit. The investigators plan to conduct a pilot study in preparation for larger-scale clinical trial to determine the most effective maintenance approaches once MBCT has ended. The investigators gathered stakeholder input from MBCT graduates and MBCT teachers to inform the development of maintenance programs for MBCT. From this the investigators formulated several components of a maintenance program for MBCT. This includes providing a booster course for people who have already completed the MBCT program. This will be delivered as a 4-week course, meeting weekly, followed by monthly sessions to help participants build self-efficacy and agency with regard to creating their own plan for relapse prevention. This booster course is adapted from a 12-week program developed by Dr. Willem Kuyken at the Oxford Centre for Mindfulness. The team is planning the following sessions: 1 Deepening mindfulness with a focus on interoceptive awareness. 2) Hedonic system: Appreciating the light within. This would focus on positive emotion. 3) Responding not reacting 4) Two themes: taking care of ourselves, taking care of others. Integrating lessons into daily life with regards to sleep, diet, healthy relationships, behavioral activation. The study will also provide monthly follow-up sessions. The current study is a pilot study aimed at refining the intervention, providing initial data on acceptability and feasibility, and preliminary use of outcome measures in the context of the proposed study design.

NCT ID: NCT05859035 Active, not recruiting - Clinical trials for Opioid-Related Disorders

Informational App Development for mHealth for Patient Self-Management of Opioid Use Disorder

KIOS-I
Start date: June 29, 2023
Phase: N/A
Study type: Interventional

This study will evaluate the feasibility of an app that provides drug information to people in recovery from opioid use disorder. This study is designed to test the prototype app, not to determine health outcomes. The study will confirm the design and operating specifications prior to being evaluated in a larger clinical trial.

NCT ID: NCT05858905 Active, not recruiting - Clinical trials for Peripheral Arterial Disease

FORWARD PAD IDE Study With the Shockwave Mini S IVL Catheter

FORWARD PAD
Start date: June 27, 2023
Phase: N/A
Study type: Interventional

The FORWARD PAD IDE Study is a prospective, multi-center, single-arm investigational device exemption study, conducted to assess the safety and effectiveness of the Shockwave Medical Mini S Peripheral IVL System for the treatment of heavily calcified, stenotic peripheral arteries.

NCT ID: NCT05856435 Active, not recruiting - Behavior Problem Clinical Trials

Tailoring CPP for the Foster Care Setting

CPP-FC
Start date: May 16, 2023
Phase: N/A
Study type: Interventional

The primary objective of this study is to tailor the Chicago Parent Program, an evidence-based parent training program, for the foster care setting and pilot the content in two cohorts of foster and kinship caregivers (Gross et al., 2009).

NCT ID: NCT05854992 Active, not recruiting - Clinical trials for Cardiovascular Diseases

Treatments of Migraine With Triptans in Individuals With Elevated Cardiovascular Risk and in Pregnant Women

Start date: July 5, 2022
Phase:
Study type: Observational

Researchers are evaluating the safety of triptan treatment of migraine in individuals with elevated cardiovascular risk and in pregnant women.

NCT ID: NCT05853354 Active, not recruiting - Clinical trials for Osteoporosis, Postmenopausal

Comparative Efficacy, Safety, PK, and Immunogenicity Study

Start date: April 5, 2023
Phase: Phase 3
Study type: Interventional

this comparative clinical study is designed to demonstrate that LY06006 and EU-Prolia have no clinically meaningful differences in clinical efficacy, pharmacodynamic (PD), safety, PK, and immunogenicity in postmenopausal women with osteoporosis.